145 related articles for article (PubMed ID: 36397978)
1. Optimizing Expectations About Endocrine Treatment for Breast Cancer: Results of the Randomized Controlled PSY-BREAST Trial.
Shedden-Mora MC; Pan Y; Heisig SR; von Blanckenburg P; Rief W; Witzel I; Albert US; Nestoriuc Y
Clin Psychol Eur; 2020 Mar; 2(1):e2695. PubMed ID: 36397978
[TBL] [Abstract][Full Text] [Related]
2. Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial.
von Blanckenburg P; Schuricht F; Albert US; Rief W; Nestoriuc Y
BMC Cancer; 2013 Sep; 13():426. PubMed ID: 24047450
[TBL] [Abstract][Full Text] [Related]
3. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study.
Nestoriuc Y; von Blanckenburg P; Schuricht F; Barsky AJ; Hadji P; Albert US; Rief W
Ann Oncol; 2016 Oct; 27(10):1909-15. PubMed ID: 27551051
[TBL] [Abstract][Full Text] [Related]
4. Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study.
Pan Y; Heisig SR; von Blanckenburg P; Albert US; Hadji P; Rief W; Nestoriuc Y
Breast Cancer Res Treat; 2018 Apr; 168(3):667-677. PubMed ID: 29330625
[TBL] [Abstract][Full Text] [Related]
5. What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy.
Heisig SR; Shedden-Mora MC; von Blanckenburg P; Rief W; Witzel I; Albert US; Nestoriuc Y
Psychooncology; 2016 Dec; 25(12):1485-1492. PubMed ID: 26913587
[TBL] [Abstract][Full Text] [Related]
6. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract][Full Text] [Related]
7. Pilot randomized controlled trial of a program to enhance experience and adherence with adjuvant endocrine therapy among women with non-metastatic breast cancer: 12-month quantitative results.
Assan O; Memoli V; Guillaumie L; Turcotte V; Lemay M; Dionne A; Lemieux J; Provencher L; Gotay C; de Bruin M; Guénette L; Lauzier S
J Cancer Surviv; 2024 May; ():. PubMed ID: 38702555
[TBL] [Abstract][Full Text] [Related]
8. Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial.
Rief W; Shedden-Mora MC; Laferton JA; Auer C; Petrie KJ; Salzmann S; Schedlowski M; Moosdorf R
BMC Med; 2017 Jan; 15(1):4. PubMed ID: 28069021
[TBL] [Abstract][Full Text] [Related]
9. Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.
Labonté M; Guillaumie L; Dionne A; Dorval M; Nabi H; Lemieux J; Provencher L; Lauzier S
Res Social Adm Pharm; 2020 Dec; 16(12):1724-1736. PubMed ID: 32205070
[TBL] [Abstract][Full Text] [Related]
10. Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients.
Quidde J; Pan Y; Salm M; Hendi A; Nilsson S; Oechsle K; Stein A; Nestoriuc Y
BMC Cancer; 2018 Sep; 18(1):916. PubMed ID: 30249191
[TBL] [Abstract][Full Text] [Related]
11. Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial.
Ream ME; Walsh EA; Jacobs JM; Taub C; Lippman M; Schaefer-Solle N; Safren SA; Antoni MH
Breast Cancer Res Treat; 2021 Nov; 190(1):79-88. PubMed ID: 34410568
[TBL] [Abstract][Full Text] [Related]
12. The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jacobs JM; Walsh EA; Park ER; Berger J; Peppercorn J; Partridge A; Horick N; Safren SA; Temel JS; Greer JA
Int J Behav Med; 2020 Dec; 27(6):687-697. PubMed ID: 32495240
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence.
Brett J; Boulton M; Fenlon D; Hulbert-Williams NJ; Walter FM; Donnelly P; Lavery BA; Morgan A; Morris C; Watson EK
Patient Prefer Adherence; 2018; 12():291-300. PubMed ID: 29497284
[TBL] [Abstract][Full Text] [Related]
14. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
15. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
[TBL] [Abstract][Full Text] [Related]
16. Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study.
Heisig SR; Shedden-Mora MC; Hidalgo P; Nestoriuc Y
Health Psychol; 2015 Oct; 34(10):1033-1037. PubMed ID: 25689300
[TBL] [Abstract][Full Text] [Related]
17. Optimizing preoperative expectations leads to a shorter length of hospital stay in CABG patients: Further results of the randomized controlled PSY-HEART trial.
Auer CJ; Laferton JAC; Shedden-Mora MC; Salzmann S; Moosdorf R; Rief W
J Psychosom Res; 2017 Jun; 97():82-89. PubMed ID: 28606503
[TBL] [Abstract][Full Text] [Related]
18. Decision-making in the multiphase optimization strategy: Applying decision analysis for intervention value efficiency to optimize an information leaflet to promote key antecedents of medication adherence.
Green SMC; Smith SG; Collins LM; Strayhorn JC
Transl Behav Med; 2024 May; ():. PubMed ID: 38795061
[TBL] [Abstract][Full Text] [Related]
19. Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.
Humphries B; Collins S; Guillaumie L; Lemieux J; Dionne A; Provencher L; Moisan J; Lauzier S
Pharmacy (Basel); 2018 Jun; 6(2):. PubMed ID: 29890738
[TBL] [Abstract][Full Text] [Related]
20. Possible alleviation of symptoms and side effects through clinicians' nocebo information and empathy in an experimental video vignette study.
Meijers MC; Stouthard J; Evers AWM; Das E; Drooger HJ; Jansen SJAJ; Francke AL; Plum N; van der Wall E; Nestoriuc Y; Dusseldorp E; van Vliet LM
Sci Rep; 2022 Sep; 12(1):16112. PubMed ID: 36167876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
